Fairness for Patient Medications Act

The Fairness for Patient Medications Act, also known as Bill 118 hr 3285, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the issue of high prescription drug costs for patients by prohibiting pharmacy benefit managers (PBMs) from charging patients more for their medications than the actual cost of the drug.

The bill aims to increase transparency in the pricing of prescription drugs by requiring PBMs to pass on any discounts or rebates they receive from drug manufacturers to patients at the point of sale. This would help to ensure that patients are not overcharged for their medications and would help to lower out-of-pocket costs for consumers.

Additionally, the Fairness for Patient Medications Act would require PBMs to provide patients with information on the lowest cost alternative for their prescription drugs, as well as information on any available financial assistance programs. This would help patients make more informed decisions about their healthcare and potentially save them money on their medications. Overall, the Fairness for Patient Medications Act aims to increase transparency and fairness in the pricing of prescription drugs, ultimately helping to lower costs for patients and improve access to affordable healthcare.